HONG KONG--(BUSINESS WIRE)--Great Bay Bio, a leading biotechnology company dedicated to innovative drug CMC (Chemistry Manufacturing and Controls) and pre-clinical development of big data service ...
HONG KONG, Dec. 1, 2021 /PRNewswire/ -- Great Bay Bio (hereinafter referred to as "GBB") is pleased to announce today the completion of its near USD 10M series A fundraising led by Proxima Ventures.
Great Bay Bio was Founded to Build a Platform for CMC Technology and Pre-Clinical Research and Development of Big Data Services for Innovative Drugs, Dr. Michael Chan as CEO [June 03, 2019 - Hong Kong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results